AARD — Aardvark Therapeutics Inc
Aardvark Therapeutics Inc (AARD) is listed on NASDAQ.
It operates in the HEALTHCARE sector (BIOTECHNOLOGY).
If you are here to check Aardvark Therapeutics Inc before deciding, you get an interactive chart, momentum and risk scores, current headlines and alerts you can set on AARD.
The scores shown here come from a model trained on real market data across seven technical indicators; it estimates both the probability of a rise and the level of risk, and shows both openly.
What AARD is
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. The company is headquartered in San Diego, California.…
Aardvark Therapeutics Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
AARD size and valuation
At roughly $110.3M, AARD is a micro-cap.
Earnings per share are negative at -3.10, so there is no meaningful price-to-earnings multiple to quote.
AARD over the past year
Over the past year AARD has traded between $3.35 and $17.23, and the current price sits at -16% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $6.07 against a 200-day average of $7.33 — the shorter average sits below the longer one, usually read as a downtrend.
The published analyst target is $11.11, 849.6% above it. A target is an aggregate of opinions, not a measurement.
How Aardvark Therapeutics Inc (AARD) is trading
Aardvark Therapeutics Inc (AARD) is up 5.41% at $1.17. A move that large in a single session sits well outside the normal daily range for most stocks.
The session ranged from $1.09 to $1.18 — 7.7% of the share price — and the current price sits at 89% of that range.
It opened at 11% of the daily range and finished at 89% of it: AARD turned around inside the session, in the buyers' favour.
Volume ran near 221.8K shares, about $259.6K of stock changing hands.
Traded alongside AARD
Names traded alongside AARD in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc), ABOS (Acumen Pharmaceuticals Inc).
What VAQO's model says about AARD
Two statistical models run over AARD inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Instrument details
- Symbol: AARD
- Name: Aardvark Therapeutics Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
AARD — frequently asked questions
What is the market cap of AARD?
Aardvark Therapeutics Inc has a market capitalisation of roughly $110.3M.
What is the 52-week range for AARD?
AARD has traded between $3.35 and $17.23 over the past year, with the current price at -16% of that range.
How much does AARD stock cost today?
Aardvark Therapeutics Inc (AARD) trades at $1.17, a change of +5.41% in the latest session.
Is AARD up or down today?
AARD is up 5.41% in the latest session, at $1.17.
What is the daily trading range for AARD?
AARD traded between $1.09 and $1.18 in the latest session, and currently trades at $1.17.
What is the trading volume for AARD?
AARD traded roughly 221.8K shares in the latest session.
Which exchange is AARD listed on?
AARD is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy AARD stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The AARD figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
More HEALTHCARE stocks
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
- ABSI — Absci Corp
Last updated: 2026-11-08